Excalibur Pharmaceuticals, Inc.
1 clinical trials · Sponsor
◉ Watch Excalibur Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Randomized, Crossover, Multi-Dose Pharmacokinetics of EXCL-100 Pirfenidone-Sustained Release Tablet and Esbriet in Healthy Volunteers (NCT05428150) | Excalibur Pharmaceuticals, Inc. | 2022-08-08 |
Track Excalibur Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.